Fundz

Wolfram in talks to acquire Ellipses Pharma

PRIVATENov 16, 2026

Acquiring Company

Wolfram Resources PLC

Acquired Company

Ellipses Pharma Limited

United KingdomUnited Arab EmiratesBiotechnologyBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

Wolfram Resources PLC confirmed active discussions regarding the potential acquisition of Ellipses Pharma Ltd, responding to press speculation. The Potential Acquisition would be an initial transaction under UK Listing Rules, so the Company requested suspension of its Ordinary Shares from listing and trading on the LSE Main Market. Trading will remain suspended until completion of the deal or an announcement that it will not proceed.

Quick answer

Wolfram Resources PLC is acquiring Ellipses Pharma Limited, announced November 16, 2026. Wolfram Resources PLC is based in United Kingdom.

How much did Wolfram Resources PLC pay for Ellipses Pharma Limited?
The deal value was not disclosed.
What does Wolfram Resources PLC do?
Wolfram Resources PLC is a company listed on the London Stock Exchange under the ticker WFR.
Where are Wolfram Resources PLC and Ellipses Pharma Limited based?
Wolfram Resources PLC is based in United Kingdom. Ellipses Pharma Limited is based in United Arab Emirates.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Therapeutics

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Wolfram Resources PLC, and when

When Wolfram Resources PLC changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Wolfram Resources PLC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Wolfram Resources PLC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Wolfram Resources PLC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Wolfram Resources PLC

Location

United Kingdom

About

Wolfram Resources PLC is a company listed on the London Stock Exchange under the ticker WFR. It is currently in active discussions regarding a potential acquisition of Ellipses Pharma Ltd. The company has requested suspension of its listing and trading pending the outcome of the potential deal.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Wolfram Resources PLC makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Wolfram Resources PLC's next move

Learn about Strategic plan

Frequently asked

Who acquired Ellipses Pharma Limited?

Ellipses Pharma Limited was acquired by Wolfram Resources PLC, based in United Kingdom. The deal was reported on November 16, 2026. Wolfram Resources PLC is a company listed on the London Stock Exchange under the ticker WFR. It is currently in active discussions regarding a potential acquisition of Ellipses Pharma Ltd. Wolfram Resources PLC is privately held and operates in Biotechnology.

When did Wolfram Resources PLC acquire Ellipses Pharma Limited?

Wolfram Resources PLC's acquisition of Ellipses Pharma Limited was reported on November 16, 2026. Wolfram Resources PLC confirmed active discussions regarding the potential acquisition of Ellipses Pharma Ltd, responding to press speculation. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Ellipses Pharma Limited do?

Ellipses Pharma Limited is a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model. It is privately held, operating in Biotechnology, and is based in United Arab Emirates.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.